Daniel Duncan

Dr. Daniel Duncan

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
NHNarutoshi Hibino
Narutoshi Hibino
TYTai Yi
Tai Yi
DDDaniel Duncan
Daniel Duncan
ARAnimesh Rathore
Animesh Rathore
EDEthan Dean
Ethan Dean
CBChristopher K. Breuer
Christopher K. Breuer
The primary graft‐related complication during the first clinical trial evaluating the use of tissue‐engineered vascular grafts (TEVGs) was stenosis. We investigated the role of macrophages in the formation of TEVG stenosis in a murine model. We analyzed the natural history of TEVG macrophage infiltration at critical time points and evaluated the role of cell seeding on neovessel formation. To assess the function of infiltrating macrophages, we implanted TEVGs into mice that had been macrophage depleted using clodronate liposomes. To confirm this, we used a CD11b‐diphtheria toxin‐receptor (DTR) transgenic mouse model. Monocytes infiltrated the scaffold within the first few days and initially transformed into M1 macrophages. As the scaffold degraded, the macrophage infiltrate disappeared. Cell seeding decreased the incidence of stenosis (32% seeded, 64% unseeded, P= 0.024) and the degree of macrophage infiltration at 2 wk. Unseeded TEVGs demonstrated conversion from M1 to M2 phenotype, whereas seeded grafts did not. Clodronate and DTR inhibited macrophage infiltration and decreased stenosis but blocked formation of vascular neotissue, evidenced by the absence of endothelial and smooth muscle cells and collagen. These findings suggest that macrophage infiltration is critical for neovessel formation and provides a strategy for predicting, detecting, and inhibiting stenosis in TEVGs.—Hibino, N., Yi, T., Duncan, D. R., Rathore, A., Dean, E., Naito, Y., Dardik, A., Kyriakides, T., Madri, J., Pober, J. S., Shinoka, T., Breuer, C. K. A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts. FASEB J. 25, 4253–4263 (2011). www.fasebj.org

1 June 2010 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
GVGustavo A. Villalona
Gustavo A. Villalona
BUBrooks Udelsman
Brooks Udelsman
DDDaniel Duncan
Daniel Duncan
EMEdward McGillicuddy
Edward McGillicuddy
RSRajendra F. Sawh-Martinez
Rajendra F. Sawh-Martinez
CBChristopher K. Breuer
Christopher K. Breuer
Previous studies have demonstrated the benefits of cell seeding in the construction of tissue-engineered vascular grafts (TEVG). However, seeding methods are diverse and no method is clearly superior in either promoting seeding efficiency or improving long-term graft function. As we head into an era during which a variety of different TEVG are under investigation in clinical trials around the world, it is important to consider the regulatory issues surrounding the translation of these technologies. In this review, we summarize important advances in the field of vascular tissue engineering, with particular attention on cell-seeding techniques for TEVG development and special emphasis placed on regulatory issues concerning the clinical translation of these various methods.

1 April 2011 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
YNYuji Naito
Yuji Naito
TSToshiharu Shinoka
Toshiharu Shinoka
DDDaniel Duncan
Daniel Duncan
NHNarutoshi Hibino
Narutoshi Hibino
DSDaniel Solomon
Daniel Solomon
CBChristopher K. Breuer
Christopher K. Breuer

1 August 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
NHNarutoshi Hibino
Narutoshi Hibino
GVGustavo Villalona
Gustavo Villalona
NPNicholas Pietris
Nicholas Pietris
DDDaniel Duncan
Daniel Duncan
ASAdam Schoffner
Adam Schoffner
CBChristopher K. Breuer
Christopher K. Breuer
We developed a tissue‐engineered vascular graft composed of biodegradable scaffold seeded with autologous bone marrow‐derived mononuclear cells (BMMCs) that is currently in clinical trial and developed analogous mouse models to study mechanisms of neovessel formation. We previously reported that seeded human BMMCs were rapidly lost after implantation into immunodeficient mice as host macrophages invaded the graft. As a consequence, the resulting neovessel was entirely of host cell origin. Here, we investigate the source of neotissue cells in syngeneic BMMC‐seeded grafts, implanted into immunocompetent mouse recipients. We again find that seeded BMMCs are lost, declining to 0.02% at 14 d, concomitant with host macrophage invasion. In addition, we demonstrate using sex‐mismatched chimeric hosts that bone marrow is not a significant source of endothelial or smooth muscle cells that comprise the neovessel. Furthermore, using composite grafts formed from seeded scaffold anastomosed to sex‐mismatched natural vessel segments, we demonstrate that the adjacent vessel wall is the principal source of these endothelial and smooth muscle cells, forming 93% of proximal neotissue. These findings have important implications regarding fundamental mechanisms underlying neotissue formation; in this setting, the tissue‐engineered construct functions by mobilizing the body's innate healing capabilities to “regenerate” neotissue from preexisting committed tissue cells.— Hibino, N., Villalona, G., Pietris, N., Duncan, D. R., Schoffner, A., Roh, J. D., Yi, T., Dobrucki, L. W., Mejias, D., Sawh‐Martinez, R., Harrington, J. K., Sinusas, A., Krause, D. S., Kyriakides, T., Saltzman, W. M., Pober, J. S., Shin'oka, T., Breuer, C. K. Tissue‐engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 25, 2731‐2739 (2011). www.fasebj.org

1 March 2012 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
NHNarutoshi Hibino
Narutoshi Hibino
DDDaniel Duncan
Daniel Duncan
ANAni Nalbandian
Ani Nalbandian
TYTai Yi
Tai Yi
YQYibing Qyang
Yibing Qyang
CBChristopher K. Breuer
Christopher K. Breuer

1 October 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
DDDaniel Duncan
Daniel Duncan
PMPaul D. Mitchell
Paul D. Mitchell
KLKara Larson
Kara Larson
RRRachel L. Rosen
Rachel L. Rosen